Short Interest in ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Increases By 94.3%

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 68,200 shares, a growth of 94.3% from the May 31st total of 35,100 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days. Approximately 1.9% of the company’s stock are short sold.

ThermoGenesis Price Performance

THMO stock remained flat at $0.22 during midday trading on Friday. 12,775 shares of the company’s stock were exchanged, compared to its average volume of 221,557. The stock’s 50 day simple moving average is $0.54 and its 200-day simple moving average is $0.64. ThermoGenesis has a 1 year low of $0.20 and a 1 year high of $1.82.

ThermoGenesis (NASDAQ:THMO) last posted its quarterly earnings results on Monday, April 15th. The company reported ($2.33) EPS for the quarter. The company had revenue of $2.41 million during the quarter. ThermoGenesis had a negative net margin of 153.43% and a negative return on equity of 4,838.39%. Research analysts anticipate that ThermoGenesis will post 0.08 EPS for the current fiscal year.

ThermoGenesis Company Profile

ThermoGenesis Holdings, Inc develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.